Novo Nordisk (NOVOB DC) does not expect to see a biosimilar of semaglutide in China this year, it is protected until April 2027 in China
Novo Nordisk's announcement regarding the protection of semaglutide until 2027 in China reassures investors about its market position and competitive advantage in a lucrative sector.
Johnson Controls International (JCI) Q2 2026 (USD): Adj. EPS 1.19 (exp. 1.12), Revenue 6.1bln (exp. 6.08bln); raises FY26 guidance
US sources familiar with mediation efforts for weeks have been telling NYPost, “we just have to get something on paper.” If this reporting is true (Axios), this is a big step in diplomacy — but certainly doesn’t mean we’re at the finish line
Novo Nordisk (NOVOB DC) does not expect to see a biosimilar of semaglutide in China this year, it is protected until April 2027 in China
American officials tell i24NEWS there is a feeling that we are getting closer to an agreement with Iran - but nothing is final.
Iranian journalist Gholhaki, speaking on the Axios report, says, "details of a potential Iran-US agreement appears to be distant from reality, at least in the nuclear domain"
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
The absence of a biosimilar this year suggests sustained revenue potential without immediate competitive pressures, which could positively impact the company's stock performance as the market factors in delayed competition.
Related headlines
- Apple (AAPL) announces iPhone 18 Pro and iPhone 18 Pro Max; will be AI focused with new Siri AI working across apps 1 hour ago
- Meta (META) has acquired AI startup Stilla.ai to bolster its Meta Business Agent, which powers commerce across WhatsApp, Messenger, and Instagram, reports Axios2 hours ago
- US Senator Slotkin says "We hear rumors that Trump is planning to allow Chinese cars to be sold in the U.S., as part of a larger deal"2 hours ago
- Verizon (VZ) CEO believes average revenue per account will grow in 20272 hours ago
- OpenAI's rogue agents used at least 10 additional sites for unauthorised communications2 hours ago
- US Midterm Update: Latest Polymarket pricing puts Democratic sweep at 50%; Republican midterm 2-day convention to start tonight2 hours ago
- Newsquawk Daily US Earnings Estimates: 10th September 2026 - ADBE, ORCL2 hours ago
- Visa (V) CEO says seeing steady consumer spending continuing despite challenges, reports CNBC2 hours ago
- Pinterest (PINS) says more than two-thirds of the business now comes from lower-funnel performance advertising, vs. Co. being almost entirely upper funnel four years ago3 hours ago
- US sells 17-week bills at a high rate of 3.895%, B/C 2.73x3 hours ago
- Coca Cola (KO) sasy global consumer conditions remain unven and have not materially changed in recent months3 hours ago
- Vale (VALE) CFO says they had no exposure in Radiant World4 hours ago
- US Quarterly Services Survey (Q2 2026): +3% to USD 6,418.7bln4 hours ago
- US EQUITY OPEN: Indices in the red as US/Iran tensions escalate 5 hours ago
- DoJ confirms it issues second request for Fox (FOX) and Roku (ROKU) merger with closing expected in H1 '27 5 hours ago
- Newsquawk Daily US Equity Opening News: DOW weighs exit from $20b Saudi chemicals venture; GOOG to invest $15bln in Finnish AI infrastructure5 hours ago
- Gap (GAP) hires Jamie Drew as its new head of strategic partnerships and growth, Business Insider reports6 hours ago
- US BROKER MOVES: TMO upgraded at UBS; VMC downgraded at Wells Fargo6 hours ago
- Analog Devices (ADI) and Alif Semiconductor today announced a definitive agreement under which ADI will acquire Alif in an all-cash transaction for USD 1.35bln6 hours ago
- Sam Altman privately told a group of GOP economists he does NOT support having the government own shares in OpenAI, reports Washington Sun7 hours ago
The whole workspace, free to try.
Try it free